Xeris Pharmaceuticals Correlations

XERS Stock

USD 3.54 0.07 1.94%

The current 90-days correlation between Xeris Pharmaceuticals and Seres Therapeutics is 0.15 (i.e., Average diversification). The correlation of Xeris Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Xeris Pharmaceuticals Correlation With Market

Average diversification

The correlation between Xeris Pharmaceuticals and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xeris Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xeris Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Xeris Stock please use our How to Invest in Xeris Pharmaceuticals guide.

Moving together with Xeris Stock

0.78	GILD	Gilead Sciences Sell-off Trend	Pair Corr
0.72	LFCR	Lifecore Biomedical	Pair Corr
0.65	ACAD	ACADIA Pharmaceuticals Downward Rally	Pair Corr
0.8	APLS	Apellis Pharmaceuticals	Pair Corr
0.74	SUPN	Supernus Pharmaceuticals	Pair Corr
0.84	TKNO	Alpha Teknova	Pair Corr

Moving against Xeris Stock

0.67	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.52	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.52	UPC	Universe Pharmaceuticals	Pair Corr
0.5	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.47	DNLI	Denali Therapeutics	Pair Corr
0.45	LLY	Eli Lilly	Pair Corr
0.63	AMGN	Amgen Inc	Pair Corr
0.55	RARE	Ultragenyx	Pair Corr
0.51	AKAN	Akanda Corp	Pair Corr
0.43	ALNY	Alnylam Pharmaceuticals	Pair Corr
0.42	SHPH	Shuttle Pharmaceuticals	Pair Corr
0.35	SNOA	Sonoma Pharmaceuticals	Pair Corr
0.34	APGE	Apogee Therapeutics,	Pair Corr
0.68	BKRKY	Bank Rakyat	Pair Corr
0.66	PPERY	Bank Mandiri Persero	Pair Corr
0.57	PPERF	Bank Mandiri Persero	Pair Corr
0.54	PBCRF	PT Bank Central	Pair Corr

Related Correlations Analysis

	PLX	MCRB	CDTX	IBRX	GRTX	MREO	TERN	PDSB	INZY	HOOK
PLX		0.39	0.95	-0.24	-0.22	-0.86	-0.82	-0.94	-0.93	-0.97	PLX
MCRB	0.39		0.46	-0.47	-0.34	-0.21	-0.08	-0.26	-0.2	-0.4	MCRB
CDTX	0.95	0.46		-0.36	-0.33	-0.8	-0.75	-0.9	-0.85	-0.95	CDTX
IBRX	-0.24	-0.47	-0.36		0.48	0.14	0.03	0.27	0.0	0.33	IBRX
GRTX	-0.22	-0.34	-0.33	0.48		0.24	-0.08	0.14	0.15	0.23	GRTX
MREO	-0.86	-0.21	-0.8	0.14	0.24		0.8	0.87	0.92	0.88	MREO
TERN	-0.82	-0.08	-0.75	0.03	-0.08	0.8		0.88	0.82	0.82	TERN
PDSB	-0.94	-0.26	-0.9	0.27	0.14	0.87	0.88		0.91	0.96	PDSB
INZY	-0.93	-0.2	-0.85	0.0	0.15	0.92	0.82	0.91		0.91	INZY
HOOK	-0.97	-0.4	-0.95	0.33	0.23	0.88	0.82	0.96	0.91		HOOK
	PLX	MCRB	CDTX	IBRX	GRTX	MREO	TERN	PDSB	INZY	HOOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HOOK	+ 0.96	PDSB
CDTX	+ 0.95	PLX
INZY	+ 0.92	MREO
INZY	+ 0.91	PDSB
HOOK	+ 0.91	INZY
HOOK	+ 0.88	MREO

High negative correlations

HOOK	- 0.97	PLX
HOOK	- 0.95	CDTX
PDSB	- 0.94	PLX
INZY	- 0.93	PLX
PDSB	- 0.9	CDTX
MREO	- 0.86	PLX

Risk-Adjusted Indicators

There is a big difference between Xeris Stock performing well and Xeris Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xeris Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PLX	3.02	1.15	0.38	(4.22)	2.04	(4.45)	8.00	(4.92)	21.48
MCRB	4.41	0.06	0.01	0.06	4.53	(5.91)	10.00	(6.82)	28.84
CDTX	3.74	1.52	0.41	2.95	2.84	(4.68)	12.90	(5.60)	29.06
IBRX	4.91	(0.09)	0.00	(0.09)	0.00	0.00	13.00	(8.79)	58.48
GRTX	2.93	(0.03)	0.00	0.20	0.00	0.00	7.31	(5.84)	18.16
MREO	2.66	(0.12)	0.00	(0.15)	0.00	0.00	5.34	(6.31)	18.02
TERN	3.00	(0.45)	0.00	(0.87)	0.00	0.00	5.17	(6.80)	26.61
PDSB	3.76	(0.95)	0.00	(2.74)	0.00	0.00	7.93	(8.65)	31.08
INZY	3.25	(0.67)	0.00	1.71	0.00	0.00	6.41	(7.81)	16.32
HOOK	3.03	(1.10)	0.00	11.28	0.00	0.00	6.85	(6.67)	22.36

Xeris Pharmaceuticals Corporate Management

PharmD D	Senior Affairs	Profile
Beth JD	Chief Secretary	Profile
Steven Pieper	Chief Officer	Profile
Dr MBA	CoFounder Officer	Profile
Paul JD	Senior Advisor	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC